Nomenclature and definition of hepatic encephalopathy - An update

Clinical Liver Disease

Volumn 5, Issue 3, 2015, Pages 68-70

  Allampati, Sanath ^a   Mullen, Kevin D ^a  

^a METROHEALTH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LIVER FAILURE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE DURATION; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER CIRRHOSIS; LIVER FIBROSIS; MEDICAL LITERATURE; MEDICAL RESEARCH; MEDICAL TERMINOLOGY; NEUROLOGIC DISEASE; NOMENCLATURE; PATIENT CARE; PORTOSYSTEMIC ANASTOMOSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW;

EID: 84928169910     PISSN: None     EISSN: 20462484     Source Type: Journal    
DOI: 10.1002/cld.449     Document Type: Review

References (9)

1. Mullen KD. Terminology of hepatic encephalopathy: work in evolution. Advances in Hepatic Encephalopathy & Metabolism in Liver Metabolism. Cihan Yurdaydin, Hakan Bozkaya 2000:375-380.
2. Krieger S, Jauss M, Jansen O, Theilmann L, Geissler M, Krieger D. Neuropsychiatric profile and hyperintense globus pallidus on T1-weighted magnetic resonance images in liver cirrhosis. Gastroenterology 1996;111:147-155.
3. Jover R, Compañy L, Gutiérrez A, Zapater P, Pérez-Serra J, Girona E, et al. Minimal hepatic encephalopathy and extrapyramidal signs in patients with cirrhosis. Am J Gastroenterol. 2003;98:1599-1604.
4. Ferenci P, Lockwood A, Mullen K, Tarter K, Weissenborn K, Blei AT. Hepatic encephalopathy - definition, nomenclature, diagnosis and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002;35:716-721.
5. Conn HO, Leevy CM, Vlahcevic ZR, Rodgers JB, Maddrey WC, Seeff L, etal. Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial. Gastroenterology 1977;72(4 pt 1):573-583.
6. Bajaj JS, Cordoba J, Mullen KD, Amodio P, Shawcross DL, Butterworth RF, et al. Review article: the design of clinical trials in hepatic encephalopathy - an International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) consensus statement. Aliment Pharmacol Ther. 2011;33:739-747.
7. Vilstrup H, Amodio P, Bajaj J, Cordoba J, Ferenci P, Mullen KD, et al. Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. Hepatology 2014;60:715-735.
8. Sidhu SS, Goyal O, Mishra BP, Sood A, Chhina RS, Soni RK. Rifaximin improves psychometric performance and health-related quality of life in patients with minimal hepatic encephalopathy (the RIME Trial). Am J Gastroenterol. 2011;106:307-316.
9. Prasad S, Dhiman RK, Duseja A, Chawla YK, Sharma A, Agarwal R. Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy. Hepatology. 2007;45:549-559.